^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.DBRW_DATA           
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class       Levels    Values

      id              23    10631001 10631002 11601006    
                            13031001 13991002 13991004    
                            13991007 13991009 16591006    
                            17601002 17601003 17601005    
                            17601007 17601012 17601014    
                            17661002 17661004 19731001    
                            19731006 19831001 19831005    
                            19831008 19901003             
      AVISITN          4    1 4 8 12                      
      trtn             3    1 2 3                         
      SSNRISN          2    1 2                           
      VISITTYN         1    1                             
      wk12             2    0 1                           
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                          Dimensions

              Covariance Parameters            10
              Columns in X                     28
              Columns in Z                      0
              Subjects                         23
              Max Obs per Subject               4


                    Number of Observations

          Number of Observations Read              90
          Number of Observations Used              90
          Number of Observations Not Used           0


 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       270.71533863                
          1              2       239.06076266      0.00064842
          2              1       239.02976872      0.00000645
          3              1       239.02947568      0.00000000


                   Convergence criteria met.                    


                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           1.1798
                UN(2,1)     id           0.3343
                UN(2,2)     id           1.1322
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(3,1)     id           0.4397
                UN(3,2)     id           0.7246
                UN(3,3)     id           1.3517
                UN(4,1)     id           0.7183
                UN(4,2)     id           0.9339
                UN(4,3)     id           1.0767
                UN(4,4)     id           1.7234


                        Fit Statistics

             -2 Res Log Likelihood           239.0
             AIC (Smaller is Better)         259.0
             AICC (Smaller is Better)        262.2
             BIC (Smaller is Better)         270.4
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         31.69          0.0002


                 Type 3 Tests of Fixed Effects
 
                           Num     Den
    Effect                  DF      DF    F Value    Pr > F

    BASE                     1    18.6       5.38    0.0320
    trtn                     2      18       0.01    0.9923
    wk12                     1    18.2       1.04    0.3208
    SSNRISN                  1    17.6       0.09    0.7642
    BASE*wk12                1    18.2       1.98    0.1759
    trtn*VISITTYN            0                             
    trtn*wk12                2    18.3       0.31    0.7339
    VISITTYN*wk12            0                             
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                           Num     Den
    Effect                  DF      DF    F Value    Pr > F

    trtn*VISITTYN*wk12       0                             


                      Least Squares Means
 
                     Subject'
                     s type
                     of visit            Standard
Effect         trtn  (N)       Estimate     Error    DF  t Value

trtn*VISITTYN  1     1          -1.1613    0.5123  19.8    -2.27
trtn*VISITTYN  2     1          -1.1383    0.5070  21.1    -2.25
trtn*VISITTYN  3     1          -1.0849    0.5860  21.1    -1.85

 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                            Subject'
                            s type
                            of visit
       Effect         trtn  (N)       Pr > |t|     Alpha

       trtn*VISITTYN  1     1           0.0347      0.05
       trtn*VISITTYN  2     1           0.0356      0.05
       trtn*VISITTYN  3     1           0.0781      0.05

                      Least Squares Means
 
                           Subject'
                           s type
                           of visit
      Effect         trtn  (N)          Lower       Upper

      trtn*VISITTYN  1     1          -2.2304    -0.09219
      trtn*VISITTYN  2     1          -2.1923    -0.08427
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                      Least Squares Means
 
                           Subject'
                           s type
                           of visit
      Effect         trtn  (N)          Lower       Upper

      trtn*VISITTYN  3     1          -2.3031      0.1333
 
 
 
 
 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.DBRW_DATA           
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class       Levels    Values

      id              15    10631001 10631002 11601006    
                            13031001 13991002 13991004    
                            13991007 13991009 17601005    
                            17601007 17601014 17661004    
                            19731006 19831001 19901003    
      AVISITN          4    1 4 8 12                      
      SSNRISN1         2    0 1                           


                          Dimensions

              Covariance Parameters            10
              Columns in X                     12
              Columns in Z                      0
              Subjects                         15
              Max Obs per Subject               4
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Number of Observations

          Number of Observations Read              72
          Number of Observations Used              60
          Number of Observations Not Used          12


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       179.07191005                
          1              2       157.20601928      0.00112417
          2              1       157.17013443      0.00001602
          3              1       157.16964907      0.00000001


                   Convergence criteria met.                    
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           1.5426
                UN(2,1)     id           0.4984
                UN(2,2)     id           0.9209
                UN(3,1)     id           0.6173
                UN(3,2)     id           0.7731
                UN(3,3)     id           1.6920
                UN(4,1)     id           0.7047
                UN(4,2)     id           0.8293
                UN(4,3)     id           1.1599
                UN(4,4)     id           1.5417


                        Fit Statistics

             -2 Res Log Likelihood           157.2
             AIC (Smaller is Better)         177.2
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                        Fit Statistics

             AICC (Smaller is Better)        182.4
             BIC (Smaller is Better)         184.3


                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         21.90          0.0092


                 Type 3 Tests of Fixed Effects
 
                            Num     Den
   Effect                    DF      DF    F Value    Pr > F

   BASE                       1      11       3.77    0.0782
   trtn1                      0                             
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                            Num     Den
   Effect                    DF      DF    F Value    Pr > F

   wk12                       0                             
   SSNRISN1                   1      11       0.27    0.6131
   VISITTYN1                  0                             
   BASE*wk12                  1      12       1.93    0.1898
   trtn1*VISITTYN1            0                             
   trtn1*wk12                 0                             
   wk12*VISITTYN1             0                             
   trtn1*wk12*VISITTYN1       0                             


 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Estimates
 
                              Standard
Label               Estimate     Error    DF  t Value  Pr > |t|

1 ACT-PBO  Week 4    0.06102    0.6720    11     0.09    0.9293
2 ACT-PBO  Week 4    Non-est                                   
1 ACT-PBO  Week 12   -0.1018    0.8440  11.3    -0.12    0.9061
2 ACT-PBO  Week 12   Non-est                                   

                           Estimates
 
       Label                Alpha       Lower       Upper

       1 ACT-PBO  Week 4     0.05     -1.4180      1.5400
       2 ACT-PBO  Week 4                                 
       1 ACT-PBO  Week 12    0.05     -1.9528      1.7491
       2 ACT-PBO  Week 12                                
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Contrasts
 
                                           Num    Den
 Label                                      DF     DF   F Value

 Treatment*Week 4*Subgroup Interaction                         
 Treatment*Week 12*Subgroup Interaction                        

                           Contrasts
 
        Label                                    Pr > F

        Treatment*Week 4*Subgroup Interaction          
        Treatment*Week 12*Subgroup Interaction         
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Model Information

     Data Set                     WORK.DBRW_DATA           
     Dependent Variable           CHG                      
     Covariance Structure         Unstructured             
     Subject Effect               id                       
     Estimation Method            REML                     
     Residual Variance Method     None                     
     Fixed Effects SE Method      Kenward-Roger            
     Degrees of Freedom Method    Kenward-Roger            


 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                    Class Level Information
 
      Class       Levels    Values

      id              16    10631001 11601006 13031001    
                            16591006 17601002 17601003    
                            17601007 17601012 17661002    
                            17661004 19731001 19731006    
                            19831001 19831005 19831008    
                            19901003                      
      AVISITN          4    1 4 8 12                      
      SSNRISN1         2    0 1                           


                          Dimensions

              Covariance Parameters            10
              Columns in X                     12
              Columns in Z                      0
              Subjects                         16
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                          Dimensions

              Max Obs per Subject               4


                    Number of Observations

          Number of Observations Read              88
          Number of Observations Used              62
          Number of Observations Not Used          26


                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          0              1       191.30064361                
          1              2       166.44483352      0.01394966
          2              1       165.91013198      0.00157907
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                       Iteration History
 
  Iteration    Evaluations    -2 Res Log Like       Criterion

          3              1       165.85459299      0.00003459
          4              1       165.85345281      0.00000003
          5              1       165.85345192      0.00000000


                   Convergence criteria met.                    


                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(1,1)     id           0.8927
                UN(2,1)     id           0.3925
                UN(2,2)     id           1.6251
                UN(3,1)     id           0.5816
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Covariance Parameter Estimates
 
                Cov Parm    Subject    Estimate

                UN(3,2)     id           1.2064
                UN(3,3)     id           1.8955
                UN(4,1)     id           0.5827
                UN(4,2)     id           1.4108
                UN(4,3)     id           1.4926
                UN(4,4)     id           2.1306


                        Fit Statistics

             -2 Res Log Likelihood           165.9
             AIC (Smaller is Better)         185.9
             AICC (Smaller is Better)        190.9
             BIC (Smaller is Better)         193.6
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                Null Model Likelihood Ratio Test
 
                  DF    Chi-Square      Pr > ChiSq

                   9         25.45          0.0025


                 Type 3 Tests of Fixed Effects
 
                            Num     Den
   Effect                    DF      DF    F Value    Pr > F

   BASE                       1      12       1.21    0.2927
   trtn2                      0                             
   wk12                       0                             
   SSNRISN1                   1    11.9       0.02    0.8905
   VISITTYN1                  0                             
   BASE*wk12                  1    12.1       0.66    0.4309
   trtn2*VISITTYN1            0                             
   trtn2*wk12                 0                             
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                 Type 3 Tests of Fixed Effects
 
                            Num     Den
   Effect                    DF      DF    F Value    Pr > F

   wk12*VISITTYN1             0                             
   trtn2*wk12*VISITTYN1       0                             


                           Estimates
 
                               Standard
Label                Estimate     Error    DF  t Value  Pr > |t|

1 ACT-PBO    Week 4    0.1280    0.5481    12     0.23    0.8193
2 ACT-PBO  Week 4     Non-est                                   
1 ACT-PBO  Week 12    -0.2257    0.7767  12.7    -0.29    0.7761
2 ACT-PBO  Week 12    Non-est                                   

 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Estimates
 
      Label                 Alpha       Lower       Upper

      1 ACT-PBO    Week 4    0.05     -1.0656      1.3216
      2 ACT-PBO  Week 4                                  
      1 ACT-PBO  Week 12     0.05     -1.9075      1.4562
      2 ACT-PBO  Week 12                                 


                           Contrasts
 
                                           Num    Den
 Label                                      DF     DF   F Value

 Treatment*Week 4*Subgroup Interaction                         
 Treatment*Week 12*Subgroup Interaction                        

 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Jazz Pharmace
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Protocol 150-
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Table 9.2.2.3
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}Key Secondary
^S={fontstyle=ROMAN fontsize=10pt font_weight=bold}(Modified Ful

                      The Mixed Procedure

                           Contrasts
 
        Label                                    Pr > F

        Treatment*Week 4*Subgroup Interaction          
        Treatment*Week 12*Subgroup Interaction         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
^S={}CGI-S: Clinician Global Impression of Severity; SD: Standar
^S={}Note: The Modified Full Analysis Set includes all participa
^S={}Note: The baseline (Day -1) value is generally defined as t
^S={}Note: All ICEs are addressed using the treatment policy str
^S={}Note: CGI-S is a 7-point Likert-type rating scale used to a
^S={}Note: The LS means, SEs, LS Mean Diff, 95% CI and p-value h
^S={}Note: The randomization stratification factor will be remov
^S={}PROGRAM NAME: C:\SASData\JZP-150\150-201\stat\csr_dryrun1\p
